Key result
Propafenone maintained stable sinus rhythm in 84% of patients compared to 64% with amiodarone at 18 months following bipolar radiofrequency ablation and mitral valve surgery.
Why the study?
Does propafenone improve the maintenance of stable sinus rhythm compared to amiodarone or control in patients with mitral valve disease and persistent atrial fibrillation undergoing ablation and mitral valve surgery?
RCT (n=75)
Randomized
No
Does propafenone improve the maintenance of stable sinus rhythm compared to amiodarone or control in patients with mitral valve disease and persistent atrial fibrillation undergoing ablation and mitral valve surgery?
Propafenone is more effective than amiodarone for maintaining stable sinus rhythm postoperatively in patients undergoing bipolar radiofrequency ablation combined with mitral valve surgery.
Answers are grounded in this paper and cite their sources.
May support propafenone over amiodarone for post-ablation rhythm control in mitral surgery; hypothesis-generating and requires randomized confirmation.
Background: This study aims to examine the effects of amiodarone versus propafenone for maintenance of stable sinus rhythm after left atrial bipolar radiofrequency ablation combined with a mitral valve procedure in patients with mitral valve disease and persistent atrial fibrillation. Methods: The study included 75 patients (29 males, 46 females; mean age 66,8±7.4 years; range 54 to 82 years) who underwent left atrial bipolar radiofrequency ablation combined with mitral valve surgery between July 2008 and July 2010. Patients were divided into three groups of 25: propafenone group (group 1), amiodarone group (group 2), and control group (group 3). Atrial fibrillation patients with slow ventricular response were excluded from the study. Results: Data was collected at preoperative period, during surgery, prior to discharge from hospital, and at 3, 6, and 18 months after discharge. Patients from all groups were followed for 18 months. In group 1, the number of patients in sinus rhythm was 22 at discharge, 20 at three months, and 21 at six and 18 months. In group 2, the number of patients in sinus rhythm was 18 at discharge, 13 at three months, 15 at six months, and 16 at 18 months. In group 3, the number of patients in sinus rhythm was 16 at discharge, 11 at three months, 12 at six months, and 14 at 18 months. Group 1 had a statistically significantly higher rate of stable sinus rhythm. No hospital mortality was observed in any group. Conclusion: This study revealed that propafenone was more effective than amiodarone in maintenance of stable sinus rhythm at the postoperative period in patients who underwent bipolar radiofrequency ablation combined with a mitral valve procedure.
No takes yet. Share an insight, caveat, or question.
Yüksel Beşir (2015) conducted an RCT in Mitral valve disease and persistent atrial fibrillation (n=75). Propafenone vs. Amiodarone and no anti-arrhythmic drug (control) was evaluated on Maintenance of stable sinus rhythm at 18 months (p=0.041). Propafenone maintained stable sinus rhythm in 84% of patients compared to 64% with amiodarone at 18 months following bipolar radiofrequency ablation and mitral valve surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: